Skip to Content

863 (Topiramate Extended-Release 25 mg)

Pill with imprint 863 is White, Capsule-shape and has been identified as Topiramate Extended-Release 25 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Topiramate is used in the treatment of epilepsy; seizure prevention; lennox-gastaut syndrome; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 863

Topiramate extended-release 25 mg 863

Topiramate Extended-Release

Imprint
863
Strength
25 mg
Color
White
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
68382-0863
Inactive Ingredients
alcohol, ammonia, butyl alcohol, microcrystalline cellulose, ethylcelluloses, ferrosoferric oxide, gelatin, hydrogenated castor oil, hypromelloses, isopropyl alcohol, polyethylene glycol, potassium hydroxide, povidone, propylene glycol, shellac, sodium lauryl sulfate, magnesium silicate, titanium dioxide, triethyl citrate, water

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "863"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.